Trial NCT06907797
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
- Phase
- Not given
- Sponsor
- Dana-Farber Cancer Institute
- Conditions
- Acute Leukemia; Leukemia
- Ages
- 18+ years
Eligibility criteria
Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).
Inclusion Criteria:
* Age 18 or older
* English speakingLanguage
* Ability to understand and willingness to sign written informed consent
* Clinical suspicion of acute leukemia
* Admitted to DFCI-affiliated inpatient unit
Exclusion Criteria:
* Cognitive impairment rendering the individual unable to participate in beta testing
* This will be assessed by focused chart review and consultation with the patients' inpatient care team.
* The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers <18 years old), prisoners.
* Inability to participate in in-person application testing.
* Patients who participated in alpha-testing through protocol 23-404 (Appendix A)
Restrictions found (1)
- LanguageOutrightinclusionShow in the text
Recruiting in Massachusetts
- Dana-Farber Cancer Institute · Boston, Suffolk County